A Human In Vivo Feeding Study Of The Blood Monocyte Response To Dietary Lipid Intake
NCT ID: NCT02101346
Last Updated: 2019-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
8 participants
INTERVENTIONAL
2014-10-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation
NCT04269876
Conjugated Linoleic Acid Supplementation Study
NCT01234636
The Effects of a Spread With Added Plant Sterols and Omega-3 Fatty Acids on Blood Lipids
NCT02728583
Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome
NCT02061267
Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function
NCT00600912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy, Round 1
For feeding of 5 different fatty acid meals in order to assess the monocyte response ex vivo Mixed high fat diet Low fat diet Saturated fat diet Monounsaturated fat diet Polyunsaturated fat diet
Mixed High Fat Diet
Healthy, Round 1
Saturated fat diet
Healthy, Round 1 Healthy, Round 2
Monounsaturated fat diet
Healthy, Round 1
Polyunsaturated fat diet
Healthy, Round 1
Low fat
Healthy, Round 1
Healthy, Round 2
For feeding of 2 different fatty meals, in order to assess the molecular monocyte response and track the fate of fats.
Saturated fat Triolein 13C
Saturated fat diet
Healthy, Round 1 Healthy, Round 2
Triolein 13C
Healthy, Round 2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mixed High Fat Diet
Healthy, Round 1
Saturated fat diet
Healthy, Round 1 Healthy, Round 2
Monounsaturated fat diet
Healthy, Round 1
Polyunsaturated fat diet
Healthy, Round 1
Triolein 13C
Healthy, Round 2
Low fat
Healthy, Round 1
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged between 18-65 years (inclusive)
* body mass index of between 18.5-25kg/m2
Exclusion Criteria
* Undiagnosed metabolic syndrome (assessed at initial screening)
* Current smokers
* Substance abuse
* Excess alcohol intake
* Significant medical illness including: diabetes, established cardiovascular disease, cancer, gastrointestinal disease (e.g. inflammatory bowel disease or irritable bowel syndrome), kidney, liver or pancreatic disease or autoimmune or inflammatory disease processes.
* Taking regular medications
* Major surgery in last 6 months
18 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kevin J Woollard, BSc MSc PhD
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Lipophage-14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.